[Skip to Navigation]
August 1963

Reactions to Isoniazid: Case Report and Review of the Literature

Author Affiliations


From the Department of Dermatology, The University of Michigan Medical Center.

Present address: Section of Dermatology, The University of Arkansas Medical Center, Little Rock, Ark (Dr. Honeycutt).

Arch Dermatol. 1963;88(2):190-194. doi:10.1001/archderm.1963.01590200078016

Toxic reactions to isoniazid in usual therapeutic doses (5 mg/kg) are relatively rare compared to other current antituberculous agents. Because of the prevalence of multiple-agent therapy of pulmonary tuberculosis, the dermatologist is faced with the problem of ascertaining which drug is the toxic agent. The morphology of eruptions due to isoniazid (INH) most often consists of a morbilliform or maculopapular eruption which rarely progresses to an exfoliative erythrodermatitis. The dermatologist should also be alerted to the frequent association of isoniazid drug eruptions with fever, lymphadenopathy, eosinophilia, and jaundice. In addition, there is frequently toxic or allergic involvement of other organ systems, simulating many clinical entities; ie, hepatitis, infectious mononucleosis, central and peripheral nervous system disease, blood dyscrasias, diffuse vasculitis, and a generalized hypersensitivity state.

Add or change institution